Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reema Wahdan-Alaswad

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Research|March 12, 2009
Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cellsJiayi Yang, Reema Wahdan-Alaswad, David Danielpour
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problemReema Wahdan-Alaswad, Bolin Liu, Ann D Thor
Cancer Science|September 10, 2013
Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastomaFei Tan, Reema Wahdan-Alaswad, Shuang Yan, et al.
Plos One|May 10, 2013
Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cellsKyung Song, Eswar Shankar, Jiayi Yang, et al.
Cell Cycle (Georgetown, Tex.)|February 27, 2016
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancerReema Wahdan-Alaswad, J Chuck Harrell, Zeying Fan, et al.
Cell Cycle (Georgetown, Tex.)|December 23, 2011
Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancersXin-Sheng Deng, Shuiliang Wang, Anlong Deng, et al.
Cell Cycle (Georgetown, Tex.)|October 11, 2013
Glucose promotes breast cancer aggression and reduces metformin efficacyReema Wahdan-Alaswad, Zeying Fan, Susan M Edgerton, et al.
Hormones & Cancer|July 26, 2017
The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast CancerElizabeth A Wellberg, L Allyson Checkley, Erin D Giles, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Research|March 12, 2009
Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cellsJiayi Yang, Reema Wahdan-Alaswad, David Danielpour
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problemReema Wahdan-Alaswad, Bolin Liu, Ann D Thor
Cancer Science|September 10, 2013
Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastomaFei Tan, Reema Wahdan-Alaswad, Shuang Yan, et al.
Plos One|May 10, 2013
Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cellsKyung Song, Eswar Shankar, Jiayi Yang, et al.
Cell Cycle (Georgetown, Tex.)|February 27, 2016
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancerReema Wahdan-Alaswad, J Chuck Harrell, Zeying Fan, et al.
Cell Cycle (Georgetown, Tex.)|December 23, 2011
Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancersXin-Sheng Deng, Shuiliang Wang, Anlong Deng, et al.
Cell Cycle (Georgetown, Tex.)|October 11, 2013
Glucose promotes breast cancer aggression and reduces metformin efficacyReema Wahdan-Alaswad, Zeying Fan, Susan M Edgerton, et al.
Hormones & Cancer|July 26, 2017
The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast CancerElizabeth A Wellberg, L Allyson Checkley, Erin D Giles, et al.
Pageof 1